Diploma: Specialized Distribution
What this covers
This episode of Business Breakdowns has Charlie Huggins walking through Diploma, a UK-listed group of roughly 30 to 40 specialized businesses spanning controls, seals and life sciences. He argues the company should be understood as a collection of small, independently run firms rather than one 2,500-person organization. The economics are laid out in unit terms: a component bought at 63p and sold for £1 yields about a 37% gross margin and roughly 19p of operating profit after distribution and admin costs. That model has produced high-teens EBIT margins and returns on capital near 20% for almost two decades.
The middle of the discussion covers why those returns hold up. Parts that are critical but tiny relative to the machinery they protect give pricing power, and because they are funded from operating rather than capital budgets, revenue recurs. Speed of supply matters more than price. Scale earns first allocation from suppliers during shortages, which helps explain share gains after 2009, when revenue fell 12% but seals later grew 20% and 26%. The life sciences arm, about 20% of sales, works on long, largely exclusive agreements for manufacturers who lack their own distribution in markets like Canada.
The third strand is capital allocation. Diploma buys small private businesses, mostly at single-digit EBIT multiples and deals of £100 million or below, directly from owners it has courted for years. It targets a 20% return on capital within three to five years. The conversation credits Bruce Thompson with shaping the current portfolio and notes that his short-lived would-be successor, Richard Ingram, clashed with the decentralized culture. It also covers newer leadership's shift away from cheap but non-growing targets toward structural growth areas such as renewables, data center components and building automation. Comparisons to Berkshire Hathaway, Constellation Software and Danaher frame the decentralization argument.
Diploma is a high-quality value-add distributor whose advantages come from stocking critical low-cost components, funding through operating budgets, and disciplined decentralized acquisitions, so its returns persist even though the business looks mundane.
- Critical low-cost components funded from customers' operating budgets create recurring, resilient revenue and pricing power
- Decentralized, autonomous subsidiaries plus scale and inventory breadth sustain high returns on capital and share gains after downturns
- Buying small private businesses at single-digit EBIT multiples and holding them under a listed parent creates a valuation arbitrage
Seals demand is resilient because aftermarket serves installed machinery and inventory strategy drove the rebound.
- Seals demand is driven by construction and infrastructure activity but is resilient because the aftermarket serves machinery already in service, which breaks regardless of new equipment sales.
“as long as that machinery is being operated, it will break and that lends a degree of resilience to that business.”
- Seals underlying sales fell 21% in 2009 in a construction-led downturn, then rose 20% in 2010 and 26% in 2011, a rebound the speaker attributes largely to maintaining wide inventory and preferential supplier treatment.
“In 2009 the seals business underlying sales were down 21%.”
Competitive threats differ by segment, with seals facing commoditized and OEM alternatives.
- Competition differs by segment: life sciences faces main threat from suppliers distributing directly after acquisition by large medtech firms, seals faces commoditized and OEM alternatives, and controls is the most competitive of the three.
“But I'd say controls is probably the more competitive out of the three.”
Bureaucracy should be avoided like the plague, a view the speaker attributes to Charlie Munger.
- The speaker attributes to Charlie Munger the view that bureaucracy is like cancer and should be avoided like the plague.
“I think Charlie Munger says bureaucracy is like cancer, avoid it like the plague.”